Clinical Trial Update: Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating melphalan and busulfan conditioning followed by donor peripheral stem cell transplantation with tacrolimus and methotrexate in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Alkeran (melphalan)
• Busulfex (busulfan)
• Prograf (Tacrolimus)
• Rheumatrex (methotrexate)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED